Effect of Mutations in the N-Terminal Peptide of the Coat Protein on the Structure of Potato Virus X According to Small-Angle X-Ray Scattering and Molecular Dynamics.
Small tweaks to peptide sequences can flip viral behavior on its head. Researchers just showed how swapping two amino acids in the N-terminal peptide of the Potato Virus X (PVX) coat protein completely changes the game for the virus’s RNA. This isn’t just a detail for plant virology nerds—it's a sharp demonstration of how peptide structure controls function at the deepest level.
Biochemistry (Mosc)
by Ksenofontov AL, Petoukhov MV, Arutyunyan AM et al.
“Effect of Mutations in the N-Terminal Peptide of the Coat Protein on the Structure of Potato Virus X According to Small-Angle X-Ray Scattering and Molecular Dynamics. Ksenofontov AL(1), Petoukhov MV(2), Arutyunyan AM(3), Oleynikov IP(3), Peters GS(4), Baratova LA(3), Arkhipenko MV(5), Nikitin NA(5), Karpova OV(5), Shtykova EV(2). Author information: (1)Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia. ksenofon@belozersky.msu.ru. (2)Frumkin Institute of Physical Chemistry and Electrochemistry, Russian Academy of Sciences, Moscow, 119071, Russia. (3)Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia. (4)National Research Center "Kurchatov Institute", Moscow, 123182, Russia. (5)Faculty of Biology, Lomonosov Moscow State University, Moscow, 119991, Russia. Mutations in the N-terminal peptide (Ser-Thr to Ala-Gly substitution) of the coat protein (CP) of potato virus X (PVX-ST) render its genomic RNA translationally competent, unlike in the wild-type PVX virions. Consequently, RNA within the PVX-ST virions can be translated without additional triggers (such as phosphorylation or interaction with the triple gene block 1 protein), unlike the encapsidated RNA of the wild-type virus. Comprehensive structural analysis using molecular dynamics (MD), small-angle X-ray scattering (SAXS), and tritium planigraphy revealed differences in the virion organization. The mutations were shown to increase hydrophobicity and induce partial folding of the N-terminal peptides. This triggers structural rearrangement in the PVX-ST virion: packing density of the coat proteins within the helical capsid is altered. This conclusion is supported by the SAXS data, increased accessibility for tritium labeling of the key CP domains (including the RNA-binding region), and reduced stability against the action of the sodium dodecyl sulfate detergent. The obtained results provide explanation for the mechanism by which the encapsidated RNA of the PVX-ST mutant becomes accessible to ribosomes. This mechanism is associated with structural rearrangement of the N-terminal coat protein peptide and change in the packing density of the helical capsid.”
Here’s what went down: The team replaced a Serine-Threonine pair with Alanine-Glycine in the coat protein’s N-terminal peptide. Sounds simple, but the results were wild. In wild-type PVX, the viral RNA is locked down and can’t be translated until the virus gets a special trigger. In their mutant, called PVX-ST, the RNA inside the virion was suddenly ready to be translated—no extra steps needed.
They backed this up with a battery of techniques:
Small-angle X-ray scattering (SAXS) and molecular dynamics showed the N-terminal peptide became more hydrophobic and partially folded.
This led to a looser packing of the coat proteins in the viral shell.
Key protein domains, including the RNA-binding area, became more exposed and accessible to labeling.
The capsid was less stable in detergent—proof of a structural shift.
Key takeaway: One small peptide tweak changed the whole structure, making the viral RNA available for ribosomes straight out of the gate. This opens up bigger questions about engineering peptide interactions to control how viral and other protein assemblies work.
For anyone deep into peptide research, these findings are a reminder of just how much potential sits in a few amino acids. Want to optimize your own research workflows? Check out our research tools page. Peptides: small molecules, big impact.
Related Reading
Eu(3+)-mediated dual-crosslinked collagen-mimetic peptide/sodium alginate hydrogel for 3D-printed skin wound dressings.
News · Acta BiomaterAntimicrobial-potentiated colorectal cancer therapy with synchronized tumoricidal immunity via a self-deliverable nanopeptide.
News · J Am Pharm Assoc (2003)Real-world weight impact upon tirzepatide discontinuation at a single-center endocrinology clinic in patients with overweight or obesity.
For Research Use Only
All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.